ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden · Delayed Price · Currency is SEK 5.20
-0.72 (-12.16%)
Apr 9, 2026, 5:29 PM CET
STO:EXPRS2 Market Cap
STO:EXPRS2 has a market cap or net worth of 20.9 million as of April 9, 2026. Its market cap has decreased by -64.90% in one year.
Market Cap
20.90M
Enterprise Value
-25.30M
Revenue
10.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.20
Market Cap Chart
Since July 29, 2016, STO:EXPRS2's market cap has decreased from 117.71M to 20.90M, a decrease of -82.25%. That is a compound annual growth rate of -16.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 20.90M | -62.77% |
| Dec 30, 2025 | 56.13M | 29.73% |
| Dec 30, 2024 | 43.27M | -60.11% |
| Dec 29, 2023 | 108.46M | -82.55% |
| Dec 30, 2022 | 621.64M | -45.72% |
| Dec 30, 2021 | 1.15B | 280.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AcouSort AB | 61.16M |
| Nanologica AB | 44.99M |
| Modus Therapeutics Holding AB | 35.64M |
| Guard Therapeutics International AB | 26.94M |
| 2cureX AB | 26.56M |
| Biosergen AB | 23.72M |
| Fluicell AB | 19.37M |
| Aptahem AB | 14.93M |